Free NPI Number Lookup with the Official NPI Registry
Dr. David M Katz
Home >Dr. David M Katz
NPI Number Detailed Information
Provider Information:
| Name: | Dr. David M Katz |
| Gender: | M |
| Provider License Number If Given: | MD30630 |
NPI Information:
| NPI: | 1740283480 |
| Entity Type (Individual or Organization): |
1-ind |
| Enumeration Date: | 5/26/2005 |
| Last Update Date: | 12/11/2018 |
| Reputation Report: |
Provider Business Mailing Address:
| Address: | 3202 TOWER OAKS BLVD 330 N Bethesda, MD 20852 |
| Phone Number: | 3015402700 |
| Fax Number: | 8663284322 |
Provider Business Practice Location Address:
| Address: | 3202 TOWER OAKS BLVD 330 N Bethesda, MD 20852 |
| Phone Number: | 3015402700 |
| Fax Number: | 8663284322 |
Provider Taxonomy:
| Primary: | 207WX0109X |
| Secondary (if any): | 2084N0400X |
| State: | MD |
Top Doctors in MD
About Dr. David M Katz
Dr. David M Katz (DR. DAVID M KATZ ) is A Ophthalmology Physician in N Bethesda, MD.
The NPI Number for Dr. David M Katz is 1740283480.
The current location address for Dr. David M Katz is 3202 TOWER OAKS BLVD 330 N Bethesda, MD 20852 and the contact number is 3015402700 and fax number is 8663284322.
The mailing address for Dr. David M Katz is 3202 TOWER OAKS BLVD 330 N Bethesda, MD 20852- 3015402700 (mailing address contact number - 3015402700).
A neuro-ophthalmologist is a subspecialist of ophthalmology. This physician evaluates, treats, and studies disorders of the eye, orbit and nervous system having to do with interactions of the visual motor and visual sensory systems with the central nervous system. Neuro-ophthalmologists manage patients with complex and severe neuro-ophthalmological disorders.
Provider Business Location on Map
FAQs:
What is the NPI Number for Dr. David M Katz ?
Answer: The NPI Number for Dr. David M Katz is 1740283480
Where is Dr. David M Katz located?
Answer: Dr. David M Katz is located at 3202 TOWER OAKS BLVD 330 N Bethesda, MD 20852.
What is the specialty for Dr. David M Katz ?
Answer: The Specialty of Dr. David M Katz is A Ophthalmology Physician.
Are there any online reviews for Dr. David M Katz ?
Answer: Yes! Check It Now.
Are there any other health care providers in N Bethesda, MD?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. David M Katz
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
| Provider Specialty Type | Neurology |
| Source of Provider Specialty | |
| Number of Medicare Part D Claims, Including Refills | 685 |
| Number of Standardized 30-Day Fills | 1487.7333333 |
| Aggregate Cost Paid for All Claims | 466007.52 |
| Number of Day's Supply for All Claims | 43877 |
| Number of Medicare Beneficiaries | 150 |
| Number of Claims, Including Refills, for Beneficiaries Age 65+ | 568 |
| Including Refills, for Beneficiaries Age 65+ | 1231.7333333 |
| Beneficiaries Age 65+ | 427360.86 |
| Number of Day's Supply for All Claims for Beneficaries Age 65+ | 36267 |
| Number of Medicare Beneficiaries Age 65+ | 128 |
| Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | # |
| Total Claims of Brand-Name Drugs | |
| Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
| Total Claims of Generic Drugs, Including Refills | 600 |
| Aggregate Cost Paid for Generic Drugs | 114817.37 |
| Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | * |
| Total Claims of Other Drugs, Including Refills | |
| Aggregate Cost Paid for Other Drugs | |
| Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by MAPD Plans | 83 |
| Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | 130508.03 |
| Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Standalone PDP Plans | 602 |
| Aggregate Cost Paid for Claims Filled by | 335499.49 |
| Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Low-Income Subsidy | 107 |
| Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | 17789.16 |
| Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | |
| Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | 578 |
| by Low-Income Subsidy | 448218.36 |
| Total Claims of Opioid Drugs, Including | |
| Aggregate Cost Paid for Opioid Drugs | |
| Opioid Claims | |
| Opioid_Tot_Clms divided by the Tot_Clms | |
| Total Claims of Long-Acting Opioid Drugs | |
| Aggregate Cost Paid for Long-Acting Opioid | |
| Number of Day's Supply of All Long-Acting | |
| Long-Acting Opioid Claims | |
| Opioid_LA_Tot_Clms divided by the | |
| Total Claims of Antibiotic Drugs, Including | |
| Aggregate Cost Paid for Antibiotic Drugs | |
| Antibiotic Claims | |
| Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | |
| Including Refills, for Beneficiaries Age 65+ | 0 |
| Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | 0 |
| Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
| Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | 0 |
| Average Age of Beneficiaries | 73.02 |
| Number of Beneficiaries Age Less Than 65 | 22 |
| Number of Beneficiaries Age 65 to 74 | 50 |
| Number of Beneficiaries Age 75 to 84 | 58 |
| Number of Female Beneficiaries | 87 |
| Number of Male Beneficiaries | 63 |
| Number of Non-Hispanic White | 116 |
| Number of Black or African American | |
| Number of Asian Pacific Islander | |
| Number of Hispanic Beneficiaries | 14 |
| Number of American Indian/Alaskan NativeBeneficiaries | 0 |
| Number of Beneficiaries with Race Not | |
| Only Entitlement | 127 |
| Average Hierarchical Condition Category | 1.2141033333 |
More Providers in n-bethesda , md
Dr. david M katz in Other Directories
Provider don't have other directory link yet.